BioLife Solutions
BLFS
128 hedge funds and large institutions have $967M invested in BioLife Solutions in 2020 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 30 increasing their positions, 45 reducing their positions, and 14 closing their positions.
150% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 14
90% more call options, than puts
Call options by funds: $4.03M | Put options by funds: $2.12M
54% more capital invested
Capital invested by funds: $626M → $967M (+$341M)
19% more funds holding
Funds holding: 108 → 128 (+20)
4.81% more ownership
Funds ownership: 69.21% → 74.02% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
33% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 45
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$54.6M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$39.6M |
| 3 |
THP
Tower House Partners
London,
United Kingdom
|
+$16.1M |
| 4 |
Jennison Associates
New York
|
+$15.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$9.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$28M |
| 2 |
Millennium Management
New York
|
-$13.8M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$13M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$6.01M |
BLFS Hedge Fund Activity: Q4 2020 in Review
128 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2020, worth a combined $967M — up 54% from $626M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new BLFS positions and 14 closed out — a net gain of 21 holders — while 30 added to existing stakes and 45 trimmed.
The largest buyer was Casdin Capital, adding an estimated $54.6M. The largest seller was Park West Asset Management, exiting entirely with an estimated $28M sold.
- 128 institutional investors held BioLife Solutions (BLFS) as of Q4 2020, up from 108 in Q3 2020.
- Funds reported $967M of BioLife Solutions stock for Q4 2020, up 54% quarter-over-quarter.
- 35 funds opened new BioLife Solutions positions in Q4 2020 and 14 closed out, a net change of +21 holders.
- The largest BioLife Solutions buyer in Q4 2020 was Casdin Capital, an estimated $54.6M added.
- The largest BioLife Solutions seller in Q4 2020 was Park West Asset Management, an estimated $28M sold.
Based on aggregated 13F filings for Q4 2020.